Skip to main content
SpringerLink
Log in

Health-Related Quality of Life

  • Chapter
  • First Online:
Modified Rice Bran Arabinoxylan

  • 111 Accesses

Abstract

Being diagnosed with cancer is an emotionally traumatic event that adversely affects a patient’s sense of overall function and wellbeing. Inflammation is a hallmark of cancer, with the inflammatory process aiding the proliferation and survival of malignant cells, suppressing the adaptive immune response while promoting tumour metastasis. Research has shown that rising systemic inflammation inversely correlates with the patients’ reported quality of life (QoL) and is a vital underlying mechanism leading to poor prognostic outcomes in advanced cancer. Chronic inflammation alongside cancer treatment regimens also contributes to microglial activation in the central nervous system, causing neuroinflammation. This leads to behavioural comorbidities such as depression, anxiety, fatigue, cognitive impairment, and neuropathic pain, which also adversely affect the QoL. Cancer-related malnutrition due to the activation of systemic inflammation is also a predictive factor for poor QoL. Hence, targeting inflammation is a promising approach to enhancing cancer patients’ QoL and improving treatment outcomes. Rice bran arabinoxylan compound (RBAC) is used among cancer patients to support weakened immune function during and after conventional cancer treatment. RBAC has been shown to be a safe and effective plant-based biological response modifier with immunomodulating and anti-inflammatory properties that can improve QoL. RBAC modulates the immune and inflammatory responses via direct absorption into the bloodstream and indirect modulation of gut microbiota. Numerous case studies and clinical trials have demonstrated improved QoL using RBAC among cancer patients. However, further research is required to substantiate the effect of RBAC on the QoL of cancer patients using validated instruments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP et al (2017) ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 36:1187–1196

    CAS  Google Scholar 

  • Aversa Z, Costelli P, Muscaritoli M (2017) Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol 9:369–382

    Google Scholar 

  • Baldo BA (2014) Side effects of cytokines approved for therapy. Drug Saf 37:921–943

    CAS  Google Scholar 

  • Bennett M, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S (2012) Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 153:359–365

    Google Scholar 

  • Boen CE, Barrow DA, Bensen JT, Farnan L, Gerstel A, Hendrix LH et al (2018) Social relationships, inflammation, and cancer survival. Cancer Epidemiol Biomark Prev 27:541–549

    Google Scholar 

  • Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440–447

    Google Scholar 

  • Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ (2016) Cancer cachexia: beyond weight loss. J Oncol Pract 12:1163–1171

    Google Scholar 

  • Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC et al (2017) ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 36:49–64

    CAS  Google Scholar 

  • Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579

    CAS  Google Scholar 

  • Centers for Disease Control and Prevention (2021) HRQOL concepts [Internet]. [cited 2021 Feb 22]. https://www.cdc.gov/hrqol/concept.htm

  • Chvetzoff G, Tannock I (2003) Placebo effects in oncology. J Natl Cancer Inst 95:19–29

    CAS  Google Scholar 

  • Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073–1081

    CAS  Google Scholar 

  • Coulson A, Levy A, Gossell-Williams M (2014) Monoclonal antibodies in cancer therapy: mechanisms, successes and limitations. West Indian Med J 63:650–654

    CAS  Google Scholar 

  • Cruz E, Kayser V (2019) Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics 13:33–51

    CAS  Google Scholar 

  • Davis BP, Ballas ZK (2017) Biologic response modifiers: indications, implications, and insights. J Allergy Clin Immunol 139:1445–1456

    CAS  Google Scholar 

  • de Carvalho HA, Villar RC (2018) Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo) 73:e557s

    Google Scholar 

  • Dehkordi A, Heydarnejad MS, Fatehi D (2009) Quality of life in cancer patients undergoing chemotherapy. Oman Med J 24:204–207

    Google Scholar 

  • Fayers P, Bottomley A (2002) Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 38:125–133

    Google Scholar 

  • Ghoneum M (2016) From bench to bedside: the growing use of arabinoxylan rice bran (MGN-3/Biobran) in cancer immunotherapy. Austin Immunol 1:1006

    Google Scholar 

  • Gu I, Lam WS, Marasini D, Brownmiller C, Savary B, Lee JA et al (2020) In vitro fecal fermentation patterns of arabinoxylan from rice bran on gut microbiota in normal weight and overweight/obese subjects. Curr Dev Nutr 4:1560

    Google Scholar 

  • Hajtó T, Horvath A, Papp S (2016) Improvement of quality of life in tumor patients after an immunomodulatory treatment with standardized mistletoe lectin and arabinoxylan plant extracts. Int J Neurorehabil 3:2–4

    Google Scholar 

  • Han J, Meng Q, Shen L, Wu G (2018) Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis 17:14

    Google Scholar 

  • Hernandez C, Huebener P, Schwabe RF (2016) Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene 35:5931–5941

    CAS  Google Scholar 

  • Hoenemeyer TW, Kaptchuk TJ, Mehta TS, Fontaine KR (2018) Open-label placebo treatment for cancer-related fatigue: a randomized-controlled clinical trial. Sci Rep 8:2784

    Google Scholar 

  • Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26:102–113

    Google Scholar 

  • Jocham HR, Dassen T, Widdershoven G, Halfens R (2006) Quality of life in palliative care cancer patients: a literature review. J Clin Nurs 15:1188–1195

    Google Scholar 

  • Kuroki M, Miyamoto S, Morisaki T, Yotsumoto F, Shirasu N, Taniguchi Y et al (2012) Biological response modifiers used in cancer biotherapy. Anticancer Res 32:2229–2233

    CAS  Google Scholar 

  • Kwekkeboom KL, Tostrud L, Costanzo E, Coe CL, Serlin RC, Ward SE et al (2018) The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer. J Pain Symptom Manag 55:1286–1295

    Google Scholar 

  • Laird BJA, McMillan DC, Fayers P, Fearon K, Kaasa S, Fallon MT et al (2013) The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist 18:1050–1055

    Google Scholar 

  • Laird BJA, Fallon M, Hjermstad MJ, Tuck S, Kaasa S, Klepstad P et al (2016) Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J Clin Oncol 34:2769–2775

    Google Scholar 

  • Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers (Basel) 3:3856–3893

    CAS  Google Scholar 

  • Li D, Yuan X, Liu J, Li C, Li W (2018) Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J Thorac Dis 10:5298–5307

    Google Scholar 

  • Liao S-K, Oldham RK (2018) Immunotherapy of cancer is a part of biotherapy. J Cancer Metastasis Treat 4:3

    Google Scholar 

  • Lin D, Shen L, Luo M et al (2021) Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther 6:404

    CAS  Google Scholar 

  • Lis CG, Gupta D, Lammersfeld CA, Markman M, Vashi PG (2012) Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J 11:27

    Google Scholar 

  • Liu J, Lin PC, Zhou BP (2015) Inflammation fuels tumor progress and metastasis. Curr Pharm Des 21:3032–3040

    CAS  Google Scholar 

  • Liu R, Luo F, Liu X, Wang L, Yang J, Deng Y et al (2016) Biological response modifier in cancer immunotherapy. Adv Exp Med Biol 909:69–138

    CAS  Google Scholar 

  • Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444

    CAS  Google Scholar 

  • Martin CR, Mayer EA (2017) Gut-brain axis and behavior. Nestle Nutr Inst Workshop Ser 88:45–53

    Google Scholar 

  • Masood AI, Sheikh R, Anwer RA (2013) “BIOBRAN MGN-3”; effect of reducing side effects of chemotherapy in breast cancer patients. Prof Med J 20:13–16

    Google Scholar 

  • Mattox TW (2017) Cancer cachexia: cause, diagnosis, and treatment. Nutr Clin Pract 32:599–606

    Google Scholar 

  • McAllister SS, Weinberg RA (2014) The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 16:717–727

    CAS  Google Scholar 

  • McSorley ST, Dolan RD, Roxburgh CSD, McMillan DC, Horgan PG (2017) How and why systemic inflammation worsens quality of life in patients with advanced cancer. Expert Rev Qual Life Cancer Care 2:167–175

    Google Scholar 

  • Mendis M, Leclerc E, Simsek S (2016) Arabinoxylans, gut microbiota and immunity. Carbohydr Polym 139:159–166

    CAS  Google Scholar 

  • Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174

    Google Scholar 

  • Molfino A, Iannace A, Colaiacomo MC, Farcomeni A, Emiliani A, Gualdi G et al (2017) Cancer anorexia: hypothalamic activity and its association with inflammation and appetite-regulating peptides in lung cancer. J Cachexia Sarcopenia Muscle 8:40–47

    Google Scholar 

  • Ooi SL, McMullen D, Golombick T, Pak SC (2018) Evidence-based review of BioBran/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment. Integr Cancer Ther 17:165–178

    CAS  Google Scholar 

  • Ooi SL, Pak SC, Micalos PS, Schupfer E, Zielinski R, Jeffries T et al (2020) Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): study protocol for a randomized pilot feasibility trial. Contemp Clin Trials Commun 19:100580

    Google Scholar 

  • Pastore CA, González MC, Orlandi SP (2013) Association between an inflammatory-nutritional index and nutritional status in cancer patients. Nutr Hosp 28:188–193

    Google Scholar 

  • Paterson A (2002) Therapeutic properties of biobran MGN-3. Posit Heal [Internet]. http://www.positivehealth.com/article/nutraceuticals/therapeutic-properties-of-biobran-mgn-3

  • Paulsen Ø, Laird B, Aass N, Lea T, Fayers P, Kaasa S et al (2017) The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS One 12:e0177620

    Google Scholar 

  • Pendergrass JC, Targum SD, Harrison JE (2018) Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci 15:36–44

    Google Scholar 

  • Peng J, Zhang R, Zhao Y, Wu X, Chen G, Wan D et al (2017) Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Chin J Cancer 36:96

    Google Scholar 

  • Pescatore F, Prestano C, Kichikova M (2022) RBAC and its role with the immune system. Altern Ther Health Med 28:8–10

    Google Scholar 

  • Petrovics G, Szigeti G, Hamvas S, Máté Á, Betlehem J, Hegyi G (2016) Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3-Arabinoxylane) and targeted radiofrequency heat therapy. Eur J Integr Med 8:29–35

    Google Scholar 

  • Pitman A, Suleman S, Hyde N, Hodgkiss A (2018) Depression and anxiety in patients with cancer. BMJ 361:k1415

    Google Scholar 

  • Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DSJ et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 47:2633–2641

    Google Scholar 

  • Robinson MW, Harmon C, O’Farrelly C (2016) Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol 13:267–276

    CAS  Google Scholar 

  • Roxburgh CSD, Mcmillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110:1409–1412

    CAS  Google Scholar 

  • Salas S, Mercier S, Moheng B, Olivet S, Garcia M-E, Hamon S et al (2017) Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study. Health Qual Life Outcomes 15:85

    Google Scholar 

  • Santos JC, Pyter LM (2018) Neuroimmunology of behavioral comorbidities associated with cancer and cancer treatments. Front Immunol 9:1195

    Google Scholar 

  • Schcolnik-Cabrera A, Chávez-Blanco A, Domínguez-Gómez G, Dueñas-González A (2017) Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. Am J Cancer Res 7:1107–1135

    CAS  Google Scholar 

  • Schirrmacher V (2019) From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol 54:407–419

    CAS  Google Scholar 

  • Sevenich L (2018) Brain-resident microglia and blood-borne macrophages orchestrate central nervous system inflammation in neurodegenerative disorders and brain cancer. Front Immunol 9:697

    Google Scholar 

  • Siddiqi A, Given CW, Given B, Sikorskii A (2009) Quality of life among patients with primary, metastatic and recurrent cancer. Eur J Cancer Care (Engl) 18:84–96

    CAS  Google Scholar 

  • Smith A, Cocks K, Parry D, Taylor M (2014) Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Qual Life Res 23:971–976

    Google Scholar 

  • Sochocka M, Diniz BS, Leszek J (2017) Inflammatory response in the CNS: friend or foe? Mol Neurobiol 54:8071–8089

    CAS  Google Scholar 

  • Takahara K, Sano K (2004) Life prolongation and QOL improvement effect of modified arabinoxylan from rice bran (BioBran/MGN-3) for progressive cancer. Clin Pharmacol Ther 14:267–271

    Google Scholar 

  • Tan DFS, Flores JAS (2020) The immunomodulating effects of arabinoxylan rice bran (Lentin) on hematologic profile, nutritional status and quality of life among head and neck carcinoma patients undergoing radiation therapy: a double blind randomized control trial. Radiol J Off Publ Philip Coll Radiol 12(February):11–16

    Google Scholar 

  • Vergara N, Montoya JE, Luna HG, Amparo JR, Cristal-Luna G (2013) Quality of life and nutritional status among cancer patients on chemotherapy. Oman Med J 28:270–274

    Google Scholar 

  • Wardill HR, Mander KA, Van Sebille YZA, Gibson RJ, Logan RM, Bowen JM et al (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer 139:2635–2645

    CAS  Google Scholar 

  • Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79

    Google Scholar 

  • World Health Organization (2021) WHOQOL: measuring quality of life [Internet]. [cited 2021 Feb 22]. https://www.who.int/tools/whoqol

  • Zhang W, Ye B, Liang W, Ren Y (2017) Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer. Sci Rep 7:9548

    Google Scholar 

  • Zitvogel L, Pietrocola F, Kroemer G (2017) Nutrition, inflammation and cancer. Nat Immunol 18:843

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Dentistry and Medical Sciences, Charles Sturt University, Bathurst, NSW, Australia

    Soo Liang Ooi, Sok Cheon Pak & Peter S. Micalos

Authors
  1. Soo Liang Ooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sok Cheon Pak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter S. Micalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sok Cheon Pak .

Editor information

Editors and Affiliations

  1. School of Dentistry and Medical Sciences, Charles Sturt University, Bathurst, NSW, Australia

    Sok Cheon Pak

  2. School of Dentistry and Medical Sciences, Charles Sturt University, Bathurst, NSW, Australia

    Soo Liang Ooi

  3. School of Dentistry and Medical Sciences, Charles Sturt University, Port Macquarie, NSW, Australia

    Peter S. Micalos

  4. Department of Surgery, Charles Drew University of Medicine & Science, Los Angeles, CA, USA

    Mamdooh H. Ghoneum

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ooi, S.L., Pak, S.C., Micalos, P.S. (2023). Health-Related Quality of Life. In: Pak, S.C., Ooi, S.L., Micalos, P.S., Ghoneum, M.H. (eds) Modified Rice Bran Arabinoxylan . Springer, Singapore. https://doi.org/10.1007/978-981-19-5735-2_8

Download citation

Publish with us

Policies and ethics

Search

Navigation